USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
VITI, INC.
Address:
PO Box 52
PORTLAND, OR 97207-
Phone:
N/A
URL:
N/A
EIN:
127103838
DUNS:
832239508
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $457,212.00 1
SBIR Phase II $2,948,926.00 1

Award List:

A CD8+ T cell Diagnostic to Identify Children with Pulmonary Tuberculosis

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$457,212.00
Agency:
HHS
Principal Investigator:
Melissa R. Nyendak – 503-494-7784
Abstract:
DESCRIPTION (provided by applicant): Tuberculosis (TB) disease, which results from infection with Mycobacterium tuberculosis (Mtb), is a leading cause of infectious morbidity and mortality in children lt 5 years old worldwide. In TB endemic regions, in which the vast majority of the world's… More

A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$2,948,926.00
Agency:
HHS
Principal Investigator:
Melissa R. Nyendak – 503-494-7784
Abstract:
DESCRIPTION (provided by applicant): Tuberculosis (TB) disease, which results from infection with Mycobacterium tuberculosis (Mtb), is a leading cause of infectious morbidity and mortality in children lt 5 years old worldwide. In TB endemic regions, in which the vast majority of the world's… More